RNS

Transaction in Own Shares

Retrieved on: 
Tuesday, February 6, 2024
RNS, Council, Appendix, EUR, Treasury, European Parliament, London Stock Exchange, MAR

The repurchase of own shares is executed in public trading in accordance with Regulation No.

Key Points: 
  • The repurchase of own shares is executed in public trading in accordance with Regulation No.
  • 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052.
  • After the disclosed transactions, Nordea holds 10,543,532 treasury shares for capital optimisation purposes and 4,787,315 treasury shares for remuneration purposes.
  • Details of each transaction are included as an appendix to this announcement.

Nordea Bank Abp: Repurchase of own shares on 30.01.2024

Retrieved on: 
Monday, February 5, 2024
RNS, Council, Appendix, EUR, Treasury, European Parliament, London Stock Exchange, MAR

The repurchase of own shares is executed in public trading in accordance with Regulation No.

Key Points: 
  • The repurchase of own shares is executed in public trading in accordance with Regulation No.
  • 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052.
  • After the disclosed transactions, Nordea holds 6,104,766 treasury shares for capital optimisation purposes and 4,787,315 treasury shares for remuneration purposes.
  • On behalf of Nordea Bank Abp,
    This information is provided by RNS, the news service of the London Stock Exchange.

Nordea launches Long Term Incentive Plan for 2024-2026

Retrieved on: 
Monday, February 5, 2024
GLT, Growth, LTIP, Investment, RNS, Employment, Nasdaq Helsinki, Risk, EET, London Stock Exchange, Management

Nordea Bank Abp's (Nordea) Board of Directors has today decided to continue the share-based Long Term Incentive Plan (LTIP) launched annually from 2020 for a new performance period covering the financial years 2024-2026.

Key Points: 
  • Nordea Bank Abp's (Nordea) Board of Directors has today decided to continue the share-based Long Term Incentive Plan (LTIP) launched annually from 2020 for a new performance period covering the financial years 2024-2026.
  • Nordea wants to ensure that management incentives are aligned with the shareholders' interests.
  • In support of this, the Board has decided to continue the share-based LTIP that has been approved and launched annually from 2020.
  • The LTIP shares will be delivered to the participants either through transfer of own shares held by Nordea or by issuing new shares.

Transaction in Own Shares

Retrieved on: 
Monday, February 5, 2024
RNS, Council, Appendix, EUR, Treasury, European Parliament, London Stock Exchange, MAR

The repurchase of own shares is executed in public trading in accordance with Regulation No.

Key Points: 
  • The repurchase of own shares is executed in public trading in accordance with Regulation No.
  • 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052.
  • After the disclosed transactions, Nordea holds 8,158,764 treasury shares for capital optimisation purposes and 4,787,315 treasury shares for remuneration purposes.
  • Details of each transaction are included as an appendix to this announcement.

Transaction in Own Shares

Retrieved on: 
Monday, February 5, 2024
RNS, Council, Appendix, EUR, Treasury, European Parliament, London Stock Exchange, MAR

The repurchase of own shares is executed in public trading in accordance with Regulation No.

Key Points: 
  • The repurchase of own shares is executed in public trading in accordance with Regulation No.
  • 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052.
  • After the disclosed transactions, Nordea holds 7,460,236 treasury shares for capital optimisation purposes and 4,787,315 treasury shares for remuneration purposes.
  • Details of each transaction are included as an appendix to this announcement.

EQS-News: Fiven ASA – Bond prospectus and listing of bonds

Retrieved on: 
Monday, February 5, 2024
Prospectus, RNS, Corporate bond, Nasdaq Stockholm, News, EUR, London Stock Exchange, ASA, Security (finance)

Fiven ASA ("Fiven") has issued a senior secured sustainability-linked floating rate bond loan of EUR 110,000,000, within a total framework amount of EUR 170,000,000, on the Nordic bond market.

Key Points: 
  • Fiven ASA ("Fiven") has issued a senior secured sustainability-linked floating rate bond loan of EUR 110,000,000, within a total framework amount of EUR 170,000,000, on the Nordic bond market.
  • The bonds carry a floating interest rate of EURIBOR 3m + 6.70 per cent.
  • Fiven has applied for listing of the bonds on the Corporate Bond list at Nasdaq Stockholm.
  • This information is information that Fiven ASA is obliged to make public pursuant to the EU Market Abuse Regulation.

Transaction in Own Shares

Retrieved on: 
Monday, February 5, 2024
RNS, Council, Appendix, EUR, Treasury, European Parliament, London Stock Exchange, MAR

The repurchase of own shares is executed in public trading in accordance with Regulation No.

Key Points: 
  • The repurchase of own shares is executed in public trading in accordance with Regulation No.
  • 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052.
  • After the disclosed transactions, Nordea holds 6,677,267 treasury shares for capital optimisation purposes and 4,787,315 treasury shares for remuneration purposes.
  • Details of each transaction are included as an appendix to this announcement.

EQS-News: Dividend Declaration

Retrieved on: 
Monday, February 5, 2024
RNS, London Stock Exchange, News

RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.

Key Points: 
  • RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
  • Terms and conditions relating to the use and distribution of this information may apply.
  • 01.02.2024 GMT/BST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
  • The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

JPMorgan ETFs (Ireland) ICAV: Dividend Declaration

Retrieved on: 
Thursday, February 1, 2024
RNS, London Stock Exchange

This information is provided by RNS, the news service of the London Stock Exchange.

Key Points: 
  • This information is provided by RNS, the news service of the London Stock Exchange.
  • RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
  • Terms and conditions relating to the use and distribution of this information may apply.
  • For further information, please contact [email protected] or visit www.rns.com .

Reimagine Care and Michiana Hematology Oncology Partnership Extends Cancer Care into the Homes of Patients of the Largest Cancer Provider in the Region

Retrieved on: 
Tuesday, January 30, 2024
Hospitals, Health, Telemedicine, Virtual Medicine, Managed Care, Oncology, Partnership, Multimedia, Hematology, Patient, App, Physician, RNS, SMS, MHO

Reimagine Care, the nation’s leading provider of virtual-first cancer care, announces a groundbreaking partnership with Michiana Hematology Oncology (MHO) to extend its cancer care services beyond the walls of the clinic.

Key Points: 
  • Reimagine Care, the nation’s leading provider of virtual-first cancer care, announces a groundbreaking partnership with Michiana Hematology Oncology (MHO) to extend its cancer care services beyond the walls of the clinic.
  • This partnership represents a significant step towards a more patient-centric treatment experience by integrating clinical oncology experts with technology to support MHO’s patients around the clock.
  • View the full release here: https://www.businesswire.com/news/home/20240130307604/en/
    Together, Reimagine Care and MHO are creating a comprehensive and compassionate approach to cancer care that will benefit patients significantly.
  • Our combined efforts will empower patients, enhance accessibility, and ultimately contribute to a more holistic and patient-centered healthcare model.”